# US 2022/0409677 A1 · Novel probiotic composition for regulation of intestinal immunity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0409677 A1
- Document ID: US20220409677A1
- Status: Published application
- Kind: A1
- Application number: 17/622,177
- Filed: 2019-07-23
- Published: 2022-12-29
- Earliest claimed: 2019-06-27
- Applicants: Il Dong Pharmaceutical Co., Ltd.
- Inventors: Jin Seok MOON; Tae-Yoon KIM; Hyuk-Sang KWON
- Web page: https://patentgrep.com/patent/US20220409677A1

## CPC

- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A23G 1/423: {containing microorganisms or enzymes}
- A23G 3/366: {containing microorganisms, enzymes}
- A23G 4/123: {containing microorganisms, enzymes}
- A23G 9/363: {containing microorganisms, enzymes}
- A23K 10/18: of live microorganisms
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A61K 35/745: Bifidobacteria
- A61P 1/06: Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23G: COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23K: FODDER
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention relates to a novel probiotic composition for regulation of intestinal immunity and, more specifically, to a composition including Lactobacillus johnsonii, Lactobacillus plantarum, and Bifidobacterium animalis subspecies lactis as active ingredients for suppressing inflammation and/or preventing, ameliorating, or treating inflammatory bowel diseases.

## Claims

### Claim 1

A pharmaceutical composition for preventing or treating inflammatory bowel disease, comprising Lactobacillus johnsonii, Lactobacillus plantarum and Bifidobacterium animalis subspecies lactis as an active ingredient.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the composition comprises a Lactobacillus johnsonii IDCC9203 strain, a Lactobacillus plantarum IDCC3501 strain, and a Bifidobacterium animalis subspecies lactis IDCC4301 strain.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the Lactobacillus johnsonii, Lactobacillus plantarum and Bifidobacterium animalis subspecies lactis are live cells or dead cells, respectively.

### Claim 4

A food composition for preventing or improving inflammatory bowel disease, comprising Lactobacillus johnsonii, Lactobacillus plantarum, and Bifidobacterium animalis subspecies lactis as an active ingredient.

### Claim 5 (depends on 4)

The composition according to claim 4, wherein the Lactobacillus johnsonii, Lactobacillus plantarum, and Bifidobacterium animalis subspecies lactis are live cells or dead cells, respectively.

### Claim 6

A pharmaceutical composition for anti-inflammatory, comprising Lactobacillus johnsonii, Lactobacillus plantarum, and Bifidobacterium animalis subspecies lactis as an active ingredient.

### Claim 7

A food composition for anti-inflammatory, comprising Lactobacillus johnsonii, Lactobacillus plantarum, and Bifidobacterium animalis subspecies lactis as an active ingredient.

### Claim 8

Use of a composition comprising Lactobacillus johnsonii, Lactobacillus plantarum and Bifidobacterium animalis subspecies lactis as an active ingredient for preparing a formulation for the prevention or treatment of inflammatory bowel disease.

### Claim 9

A method of treating inflammatory bowel disease, comprising administering to a subject in need thereof an effective amount of a composition comprising Lactobacillus johnsonii, Lactobacillus plantarum and Bifidobacterium animalis subspecies lactis as an active ingredient.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the inflammatory bowel disease is one or more selected from the group consisting of Crohn's disease, ulcerative colitis, intestinal Behcet's disease, and ischemic enteritis.

### Claim 11

Use of a composition comprising Lactobacillus johnsonii, Lactobacillus plantarum and Bifidobacterium animalis subspecies lactis as an active ingredient for preparing a formulation for preparing an anti-inflammatory agent.

### Claim 12

A method of inhibiting inflammation comprising administering to a subject in need thereof an effective amount of a composition comprising Lactobacillus johnsonii, Lactobacillus plantarum and Bifidobacterium animalis subspecies lactis as an active ingredient.
